African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5233

Full Length Research Paper

Serotypes and antimicrobial resistance of invasive Streptococcus pneumoniae isolates from East Algeria (2005-2011)

Abla Hecini-Hannachi
  • Abla Hecini-Hannachi
  • Département de Médecine, Faculté des Sciences Médicales, Université de Constantine 1, BP125 Chalet des pins, Constantine, 25000, Algeria
  • Google Scholar
Chafia Bentchouala
  • Chafia Bentchouala
  • Département de Médecine, Faculté des Sciences Médicales, Université de Constantine 1, BP125 Chalet des pins, Constantine, 25000, Algeria. Laboratoire central de Microbiologie, CHU IbnBadis Constantine, 25000, Algeria
  • Google Scholar
Abdesslem Lezzar
  • Abdesslem Lezzar
  • Département de Médecine, Faculté des Sciences Médicales, Université de Constantine 1, BP125 Chalet des pins, Constantine, 25000, Algeria. Laboratoire central de Microbiologie, CHU IbnBadis Constantine, 25000, Algeria
  • Google Scholar
Kaddour Belabed
  • Kaddour Belabed
  • Département de Médecine, Faculté des Sciences Médicales, Université de Constantine 1, BP125 Chalet des pins, Constantine, 25000, Algeria. Laboratoire central de Microbiologie, CHU IbnBadis Constantine, 25000, Algeria
  • Google Scholar
Hocine Laouar
  • Hocine Laouar
  • Département de Médecine, Faculté des Sciences Médicales, Université de Constantine 1, BP125 Chalet des pins, Constantine, 25000, Algeria. Laboratoire central de Microbiologie, CHU IbnBadis Constantine, 25000, Algeria
  • Google Scholar
Farida Smati
  • Farida Smati
  • Département de Médecine, Faculté des Sciences Médicales, Université de Constantine 1, BP125 Chalet des pins, Constantine, 25000, Algeria. Laboratoire central de Microbiologie, CHU IbnBadis Constantine, 25000, Algeria
  • Google Scholar


  •  Received: 18 May 2013
  •  Accepted: 02 December 2013
  •  Published: 08 January 2014

References

Azzari C, Moriondo M, Cortimiglia M, Valleriani C, Canessa C, Indolfi G, Ricci S, Nieddua B, Maurizio de Martino F, Resti M (2012). Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children. Vaccine 30:2701- 2705.
Crossref
 
Bautista-Marquez A, Richardson V, Ortiz-Orozco O et al (2013). Prevalence of pneumococcal disease, serotype distribution, and antimicrobial susceptibility in Mexican children younger than 5 years of age. Arch. Med. Res. 44:142-150.
Crossref
 
Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB (2011). Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J. Infect. Dis. 203:1360-1368.
Crossref
 
Benbachir M, Elmadaghri N, Belabbes H, Haddioui G, Benzaid H, Zaki B (2012). Eleven-year surveillance of antibiotic resistance in Streptococcus pneumoniae in Casablanca (Morocco) . Microb. Drug Resist. 18(2):157-160.
Crossref
 
Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M et al (2006). Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2(3):31.
Crossref
 
Bettinger JA, Scerfele DW, Keliner JD, Halperin SA, Vaudry W, Law B et al. (2010).The effect of routine vaccination on invasive pneumococcal infections in Canadian children immunization monitoring program, Active 2000-2007. Vaccine 28:2130-2136.
Crossref
 
Borg MA, Tiemersma E, Scicluna E, Van de Sande-Bruinsina N, de Kraker M, Monen J et al (2009). Prevalence of penicillin and erythromycin resistance among Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region. Clin. Microb. Infect. 15:232-237.
Crossref
 
Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK et al (2002). A European Study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8:278-82.
Crossref
 
Calix J, Nahm MH (2010). A new pneumococcal serotype 11E has a variability inactivated WCJE gene. J. Infect. Dis. 202(1):29-38.
Crossref
 
Centers for Diseases Control and Prevention (CDC) (2008). Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae- United States 2006-2007. MMWR- Morb Mortal Wkly Rep. 57:1353-1355.
 
Charfi F, Smaoui H, Kechrid A (2012). Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian pediatric population: A 10-year study. Vaccine 30:18-24.
Crossref
 
Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ (2008). Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg. Infect. Dis. 14:275-81.
Crossref
 
Clinical and Laboratory Standards Institute (2007). Performance standards for antimicrobial susceptibility testing In: Sixteen informational supplement CLSI. M100-S16.
 
Clinical and Laboratory Standards Institute (2011). Performance standards for antimicrobial susceptibility testing In: Twenty-first informational supplement CLSI. M100-S21;31(1).
 
Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, Fritzell B, Varon E (2010). Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 28:6114-21.
Crossref
 
Daikosa GL, Koutsolioutsoub A, Tsiodrasc S (2008). Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era. Diagn. Microbiol. Infect. Dis. 60:393-398
Crossref
 
de O Menezes AP, Campos LC, dos Santos MS, Azevedo J, Dos Santos RC, Carvalho Mda G et al (2011). Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007. Vaccine 29(6):1139-44.
Crossref
 
Dias R, Canica M (2004). Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. J. Antimicrob. Chemother. 54:1035-1039.
Crossref
 
Elmdaghri N, Benbachir M, Belabbes H, Zaki B, Benzaid H (2012). Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco).Vaccine 30:46-50.
Crossref
 
Farrell DJ, Felmingham D, Shackcloth J, Williams L, Maher K, Hope R et al (2008). Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemia in the UK and Ireland, 1999 to 2007. J. Antimicrob. Chemother. 62(2):87-95.
 
Farrell DJ, Klugman KP, Pichichero M (2007). Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J. 26:123-8.
Crossref
 
Felmingham D, Reinert RR, Hirakata Y, Rodloff A (2002). Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study and comparative in vitro activity of the ketolide, telithromycin. J. Antimicrob. Chemother. 50(1):25-37
Crossref
 
Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G et al (2009).Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J. Clin. Microbiol. 47(4):1012-20.
Crossref
 
Gant CM, Rosingh AW, López-Hontangas JL, van der Heijden M, González-Morán F, Bijlsma JJ et al. (2012). Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance. Antimicrob.Agents Chemother. 56(9):4988-4989.
Crossref
 
García-Suárez Mdel M, Villaverde R, Caldevilla AF, Méndez FJ, Vázquez F (2006). Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococccal isolates in Asturias, Spain. Jpn J. Infect. Dis. 59(5):299-05.
 
Henrichsen J (1995). Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33(10):2759-62.
 
Ho PL, Que TL, Chiu SS, Yung RW, Ng TK, Tsang DN, Seto WH, Lau YL (2004). Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001. Emerg. Infect. Dis. 10(7):1250-1257.
Crossref
 
Hoban D, Baquero F, Reed V, Felmingham D (2005). Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999-2000. Int. J. Infect. Dis. 9(5):262-273.
Crossref
 
Hoenigl M, Fussi P, Feierl G et al (2010). Antimicrobial resistance of Streptococcus pneumoniae in Southeast Austria, 1997-2008. Int. J. Antimicrob. Agents 36:24-27.
Crossref
 
Holliman RE, Liddy H, Johnson JD, Adjei O (2007). Epidemiology of invasive pneumococcal disease in Kumasi, Ghana. Trans. R. Soc. Trop. Med. Hyg. 101(4):405-13.
Crossref
 
Horacio AN, Diamantino-Miranda J, Aguiar SI et al (2012). Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections. Vaccine 30:218-24.
Crossref
 
Hyde TB, Gay K, Stephens DS, et al (2001). Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286:1857-1862.
Crossref
 
Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, Konradsen H, et al (2012). Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme Vaccine 30:3944-3950.
Crossref
 
Jefferies JM, Smith AJ, Edwards GF, McMenamin J, Mitchell TJ, Clarke SC (2010). Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J. Clin. Microbiol. 48:87-96.
Crossref
 
Jenkins SG, Farrell DJ, Patel M, Lavin BS (2005). Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J. Infect. 51:355-363.
Crossref
 
Johnson DM, Stilwell MG, Fritsche TR, et al (2006). Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn Microbiol Infect Dis. 56:69-74.
Crossref
 

Kaplan SL, Barson WJ, Lin PL, Stovall SH, Bradley JS, Tan TQ et al (2010). Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 125(3):429-436.
Crossref

Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A et al (2006). Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. Active Bacterial Core Surveillance of the Emerging Infections Program Network. N. Engl. J. Med. 354(14):1455-1463.
Crossref
 
Lee S, Lee K, Kang Y, Bae S (2010). Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005. Microb. Drug Resist. 16(2):135-42.
Crossref
 
Liu Y, Wang H, Chen M, Sun Z, Zhao R, Zhang L et al (2008). Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagn. Microbiol. Infect. Dis. 61(3):256-63.
Crossref
 
Manga NM, Ndour CT, Diop SA, Ka-Sall R, Dia NM, Seydi M, et al (2008). Adult purulent meningitis caused by Streptococcus pneumoniae in Dakar, Senegal. Med. Trop. 68(6):625-628.
 
Mehr S, Wood N (2012). Streptococcus pneumoniae - a review of carriage, infection, serotype replacement and vaccination. Paediatr. Respir. Rev. 13:258-264.
Crossref
 
MMWR (2008). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states 1998-2005. Morb Mortal Weekly Report. 57:144-148.
 
Mudhune S, Wamae M, (2009). Network surveillance for pneumococcal Disease in the East African Region. Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumoniae from the Network for Surveillance of Pneumococcal Disease in the East African Region. Clin. Infect. Dis. 48(2):147-52.
Crossref
 
Munoz-Almagro C, Esteva C, de Sevilla MF et al (2009). Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. J. Infect. 59:75-82.
Crossref
 
Myint TT, Madhava H, Balmer P, Christopoulou D, Attal S, Menegas D et al (2013). The Impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: A Literature Review. Adv. Ther. 30:127-51.
Crossref
 
Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA et al (2013). Changes in the molecular epidemiology of Streptococcus pneumoniae causing meningitis following the introduction of pneumococcal conjugate vaccination in England and Wales. J. Clin. Microbiol. 51:820-827.
Crossref
 
Pneumococcal conjugate vaccine for childhood immunization-WHO position paper (2007). Wikly Epidemiol Rec. 82(12):93-104.
 
Ramdani-Bouguessa N, Rahal K (2003). Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolated in Algiers, Algeria. Antimicrob. Agents Chemother. 47:824-6.
Crossref
 
Reinert RR (2009). The antimicrobial resistance profile of Streptococcus pneumoniae. Clin. Microbiol. Infect. 15(3):7-11.
Crossref
 
Reinert RR, Paradiso P, Fritzell B (2010). Advances in pneumococcal vaccines: the 13- valent pneumococcal conjugate vaccine received market authorization in Europe. Expert Rev Vaccines 9:229-236.
Crossref
 
Reinert RR, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P (2005). Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob. Agents Chemother. 49(7):2903-2913.
Crossref
 
Rosen JB, Thomas AR, Lexau CA et al (2011). Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect. Dis. 53:137- 143.
Crossref
 
Shin J, Baek JY, Kim SH, Song JH, Ko KS (2011). Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries. J. Antimicrob. Chemother. 66(5):1001-1004.
Crossref
 
Silberbauer EJ, Ismail N, Gottberg AV, Hoosen AA (2011). Serotype and antimicrobial profile distribution of invasive pneumococcal isolates in the pre-vaccine introduction era in Pretoria,South Africa, 2005 through 2009. Diagn. Microbiol. Infect. Dis. 71:309-311.
Crossref
 
Smaoui H, Amri J, Hajji N, Kechrid A (2009). Antimicrobial susceptibility and serotype distribution of streptococcus pneumoniae isolates in children in Tunis. Archives de Pédiatrie 16:220-226.
Crossref
 
Smati F, Laouar H, Khalifa F, Bentchouala C, Hacini A, Lezzar A (1994). Resistance of Streptococcus pneumoniae to penicillin. Med. Mal. Infect. 24:1190-2.
Crossref
 
Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, Lee NY, Yang Y, Lu Q, Chongthaleong A, Chiu CH, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Jamal F, Kamarulzaman A, Parasakthi N, Van PH, Carlos C, So T, Ng TK, Shibl A (2004a). High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ASNORP study). Antimicrob. Agents Chemother. 48:2101-2107.
Crossref
 
Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS et al (2004b). Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian network for surveillance of resistant pathogens (ANSORP). J. Antimicrob. Chemother. 53:457-63.
Crossref
 
Tali-Maamar H, Laliam R, Bentchouala C, Touati D, Sababou K, Azrou S et al (2012). Reprint of: Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010.Vaccine 30(6):25-31.
Crossref
 
Thomas K, Mukkai KL, Veeraraghavan B et al (2013). Invasive pneumococcal disease associated with high case fatality in India. J. Clin. Epidemiol. 66:36-43.
Crossref
 
Tóthpál A, Laub K, Kardos S, Nagy K, Dobay O (2012). Changes in the serotypes of Hungarian pneumococci isolated mainly from invasive infections: a review of all available data between 1988 and 2011. Acta Microbiol. Immunol. Hung. 59(3):423-33.
Crossref
 
Tyrrell GJ, Lovgren M, Chui N, Minion J, Garg S, Kellner JD, Marrie TJ (2009). Serotypes and antimicrobial susceptibilities of invasive
 
Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006. Vaccine 27(27):3553-3560.
Crossref
 
van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H et al (2008). Antimicrobial drug use and resistance in Europe. Emerg. Infect. Dis.14:1722-30.
Crossref
 
Van der Linden M, Weib S, Falkenhorst G, Siedler A, Imöhl M, von Kries R (2012). Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children. Vaccine 30(40):5880-5885.
Crossref
 
Varon E (2012). Epidemiology of Streptococcus pneumoniae. Med. Mal. Infect. 42:361-365.
Crossref
 
Watson M, Brett M, Brown M, Stewart MG, Warren S (2007). Pneumococci responsible for invasive disease and discharging ears in children in Sydney, Australia. J. Med. Microbiol. 56:819-823.
Crossref
 
Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A et al (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343:1917-1924.
Crossref
 
Yang F, Xu XG, Yang MJ, Zhang YY, Klugman KP, McGee L (2008). Antimicrobial susceptibility and molecular epidemiology of Streptococcus pneumoniae isolated from Shanghai, China. Int. J. Antimicrob. Agents 32:386-91.
Crossref
 
Zhou L, Yu SJ, Gao W, Yao KH, Shen A, Yang Y (2011). Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010.Vaccine 29:7704-7710.
Crossref